Ranok Therapeutics
China - HangzhouBiotechnology
Focus: Ranok Therapeutics is a China-based biotechnology company pioneering targeted protein degradation technology for oncology drug discovery and development. The company operates as a pre-revenue biotech focused on novel mechanism-of-action therapeutics.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Ranok Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Ranok Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RNK08954
Food EffectClinical Trials (1)
NCT07334262A Study to Evaluate the Food Effect on RNK08954 in Healthy Participants, and the Mass Balance Study of [14C]RNK08954 in Healthy Adult Male Subjects
Phase 1Help build intelligence for Ranok Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.